JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
UBA
2376
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $6.32M | ﹤0.01% |
290,760
+24,346
| +9% | +$544K |
2013 Q2
18 quarters
|
|
2377
Clean Harbors
CLH
$16.7B
| $6.31M | ﹤0.01% |
116,346
+6,088
| +6% | +$330K |
2013 Q2
18 quarters
|
|
2378
Watts Water Technologies
WTS
$12.2B
| $6.3M | ﹤0.01% |
82,921
-8,495
| -9% | -$606K |
2013 Q2
18 quarters
|
|
|
MLNX
2379
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $6.29M | ﹤0.01% |
97,253
+72,968
| +300% | +$3.86M |
2015 Q4
8 quarters
|
|
|
IPXL
2380
DELISTED
Impax Laboratories, Inc.
IPXL
| $6.29M | ﹤0.01% |
377,799
+71,937
| +24% | +$1.32M |
2013 Q2
18 quarters
|
|
|
AGC
2381
DELISTED
Advent Claymore Conv Sec & Incme
AGC
| $6.29M | ﹤0.01% |
1,049,275
+23,516
| +2% | +$143K |
2013 Q2
18 quarters
|
|
|
FBRX
2382
DELISTED
Forte Biosciences
FBRX
| $6.27M | ﹤0.01% |
1,632
-49
| -3% | -$196K |
2017 Q2
2 quarters
|
|
|
ATSG
2383
DELISTED
Air Transport Services Group
ATSG
| $6.27M | ﹤0.01% |
+270,989
| New | +$6.48M |
2017 Q4
0 quarters
|
|
2384
Weibo
WB
$1.56B
| $6.26M | ﹤0.01% |
60,534
-139,836
| -70% | -$14.5M |
2015 Q4
8 quarters
|
|
2385
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
| $6.26M | ﹤0.01% |
71,639
+1,465
| +2% | +$128K |
2013 Q2
18 quarters
|
|
2386
Hyster-Yale Materials Handling
HY
$554M
| $6.25M | ﹤0.01% |
73,383
-34,346
| -32% | -$2.83M |
2013 Q2
18 quarters
|
|
|
SEMG
2387
DELISTED
SEMGROUP CORPORATION
SEMG
| $6.24M | ﹤0.01% |
206,483
+2,776
| +1% | +$73.2K |
2013 Q2
18 quarters
|
|
2388
ProPetro Holding
PUMP
$1.1B
| $6.23M | ﹤0.01% |
309,199
-67,632
| -18% | -$1.15M |
2017 Q1
3 quarters
|
|
|
DVAX
2389
DELISTED
Dynavax Technologies
DVAX
| $6.22M | ﹤0.01% |
332,781
-74,157
| -18% | -$1.49M |
2016 Q3
5 quarters
|
|
2390
Xencor
XNCR
$1.89B
| $6.22M | ﹤0.01% |
283,641
-984
| -0.3% | -$21.3K |
2013 Q4
16 quarters
|
|
2391
CALL
Simon Property Group
SPG
$65.4B
| $6.22M | ﹤0.01% |
36,200
| – | – |
2017 Q2
2 quarters
|
|
|
DERM
2392
DELISTED
Dermira, Inc.
DERM
| $6.22M | ﹤0.01% |
223,547
-6,578
| -3% | -$174K |
2015 Q4
8 quarters
|
|
2393
Pacira BioSciences
PCRX
$992M
| $6.21M | ﹤0.01% |
136,062
-61,640
| -31% | -$2.44M |
2013 Q2
18 quarters
|
|
2394
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $6.21M | ﹤0.01% |
242,062
+27,386
| +13% | +$709K |
2016 Q2
6 quarters
|
|
|
2395
PUT
Weibo
WB
$1.56B
| $6.21M | ﹤0.01% |
60,000
| – | – |
2017 Q3
1 quarter
|
|
2396
Vanguard Energy ETF
VDE
$10.6B
| $6.21M | ﹤0.01% |
62,707
+50,716
| +423% | +$4.77M |
2015 Q3
9 quarters
|
|
|
POT
2397
CALL
DELISTED
Potash Corp Of Saskatchewan
POT
| $6.2M | ﹤0.01% |
+300,000
| New | +$5.82M |
2017 Q4
0 quarters
|
|
2398
POSCO
PKX
$17.4B
| $6.19M | ﹤0.01% |
79,192
+1,384
| +2% | +$102K |
2013 Q2
18 quarters
|
|
|
SCHW
2399
PUT
Charles Schwab
SCHW
$169B
| $6.18M | ﹤0.01% |
120,400
+39,100
| +48% | +$1.84M |
2017 Q3
1 quarter
|
|
2400
Lifetime Brands
LCUT
$202M
| $6.17M | ﹤0.01% |
374,137
-2,663
| -0.7% | -$47.3K |
2013 Q2
18 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.